Segment-specific verticals like LGBTQ+ care represent a growing market opportunity in the platform wars.
Unpacking the SPAC announcement from Pear Therapeutics—what this means for SPACs’ impact on the digital health market and the opportunities for the soon-to-be public Pear’s trajectory.
Historically, the fragmented nature of the U.S. healthcare system has made it nearly impossible for providers, pharmacies, and payers to collaborate and provide coordinated care—and patients have traditionally had almost no access to or control over their own health data. There has generally been little in the way of effective, HIPAA-compliant data sharing between healthcare stakeholders, leaving valuable—and potentially life-saving information—stuck in data silos.
We recently had the privilege of hosting over two dozen digital health executives from major healthcare organizations across the world for our virtual Spring Member Retreat. While representing a diverse set of organizations (provider, payer, biopharma, retail, tech) and roles (innovation, corp dev, venture), each retreat attendee shared one important characteristic—a passion for driving digital innovation within their organization. Rock Health Member Retreats are designed to be interactive, candid conversations that foster community building and generate ideas for enterprise digital innovation initiatives. And the timing of the retreat couldn’t have been any better.
Ro acquiring Modern Fertility represents the opportunity created when segment-specific services for a given population or need—in this case fertility—combine with wide-population focused virtual care platforms. This deal won’t be the last transaction where telehealth and navigation platforms snap up startups focused on segment-specific verticals.
Each year, Rock Health brings together more than 100 digital health CEOs for candid, closed-door conversations about how to build a successful company in digital health. For the 2021 Digital Health CEO Summit, co-hosted with Venture Lab at the University of Pennsylvania, we were joined by a diverse group of CEOs whose organizations’ growth stages ranged from pre-seed all the way through successful exits. Discussions focused on topics like crafting pitches, going to market, inclusive hiring practices, and navigating times of uncertainty. In this intimate setting, CEOs shared honest and valuable insights about their experiences in transforming healthcare.
Digital health has been a promising, growing space over the past decade. And with the pandemic putting new demands on the healthcare system, demand for digitally-enabled care and services spiked overnight. Even as a light has emerged at the end of the pandemic tunnel, momentum toward digital health shows no signs of slowing down. Over $14B was invested across 2020 in private US digital health companies, a number likely to be dwarfed by 2021 investment, with $6.7B already put to work in Q1 2021. With plenty of funding in tow, more companies are on their way to advancing the promise of digital transformation and achieving meaningful scale.
Yesterday, Microsoft announced it was acquiring Nuance Communications for $16B, the largest digital health acquisition since Teladongo’s starter pistol to the virtual platform wars was fired off last year. Check out our take on why big tech companies are so focused on physician workflow solutions—and what this means for their healthcare strategies going forward.
2021 opened with a whirlwind of SPAC-triggered public exit activity in digital health. In this post, we share insights and analysis on how digital health’s SPAC boom will impact four different stakeholder groups, as well as implications for the entire ecosystem.
Q1 2021 closed with $6.7B in US digital health funding, the most-funded quarter to date. Average deal size ballooned to $45.9M (up from $31.7M in 2020), and SPACs continued to offer a new path to liquidity, with 10 announced or closed SPAC deals. With growing deal sizes, a faster funding pace, and new exit pathways, we’re in a period of heightened opportunity.